In advancing pathophysiological models to assess renal drug responses, kidney organoids derived from human pluripotent stem cells mark notable progress. However, replicating aging- and senescence-related pathologies remains a challenge. In this study, an alternative model is introduced using "tubuloids"-epithelial-like structures generated from primary human renal proximal tubular epithelial cells (hRPTECs) isolated from resected human kidneys. Bulk RNA-seq deconvolution confirmed that tubuloids are highly differentiated and predominantly composed of proximal tubule-like cells. Exposure to cisplatin increased γH2AX, Kidney Injury Molecule-1, and Cleaved Caspase-3, markers for DNA damage response, epithelial damage, and apoptosis, respectively. Repeated cisplatin administration resulted in the upregulation of senescence markers and secretion of inflammatory cytokines, consistent with a senescence-associated secretory phenotype (SASP). Supernatants from cisplatin-treated tubuloids triggered myofibroblast activation, suggesting early fibrotic changes. A hRPTEC-derived tubuloid model of cisplatin-induced kidney injury is successfully developed that mimics senescence, SASP, and fibrosis-hallmarks of chronic kidney disease. This model offers a promising human-relevant platform for studying renal epithelial responses and drug screening.
A Human Kidney Tubuloid Model of Repeated Cisplatin-Induced Cellular Senescence and Fibrosis for Drug Screening.
阅读:2
作者:Nakao Yuki, Mori Makiko, Sekiguchi Yuta, Morita Iori, Shindoh Ryota, Mandai Shintaro, Fujiki Tamami, Kikuchi Hiroaki, Ando Fumiaki, Susa Koichiro, Mori Takayasu, Suzuki Ayumi, Nashimoto Yuji, Kaji Hirokazu, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa, Sohara Eisei, Uchida Shinichi, Miyake Kensuke, Mori Yutaro
| 期刊: | Advanced Healthcare Materials | 影响因子: | 9.600 |
| 时间: | 2026 | 起止号: | 2026 Feb;15(7):e01795 |
| doi: | 10.1002/adhm.202501795 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
